Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Repligen: A Business Update and Reiteration of Buy (RGEN, Buy, $34.11)

Investment Overview and Thesis

A Long Buy Recommendation of Mine

I first recommended Repligen in an initiation report in December 2012. At…
Read more…

Repligen: Fundamentals Are Exceptional But The Stock Carries A Premium Valuation (RGEN, $39.97, For Paid Subscribers)

Investment Thesis

When I wrote my first report  on Repligen on December 4, 2012, I concluded that Repligen had one of the…
Read more…